{"id":"NCT03571607","sponsor":"Pfizer","briefTitle":"A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years.","officialTitle":"A PHASE 3, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A SINGLE DOSE OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN JAPANESE SUBJECTS AGED 6 TO 64 YEARS WHO ARE CONSIDERED TO BE AT INCREASED RISK OF PNEUMOCOCCAL DISEASE AND WHO ARE NAIVE TO PNEUMOCOCCAL VACCINES","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-07-12","primaryCompletion":"2018-11-16","completion":"2018-11-16","firstPosted":"2018-06-27","resultsPosted":"2019-12-10","lastUpdate":"2020-02-18"},"enrollment":206,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Infections"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent pneumococcal conjugate vaccine","otherNames":["13vPnC"]}],"arms":[{"label":"13-valent pneumococcal conjugate vaccine","type":"EXPERIMENTAL"}],"summary":"This study is to evaluate the safety, tolerability and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese subjects aged 6 to 64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines.","primaryOutcome":{"measure":"Percentage of Participants Reporting Pre-Specified Local Reactions Within 7 Days After Vaccination in Participants Aged Between 6 to <18 Years","timeFrame":"Day 1 up to Day 7","effectByArm":[{"arm":"13vPnC: 6 to <18 Years","deltaMin":21.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":8,"countries":["Japan"]},"refs":{"pmids":["34563397"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=B1851172"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":53},"commonTop":["Pain at the injection site","Fatigue","Myalgia","Headache","Injection site swelling"]}}